US Bancorp DE Reduces Holdings in Oscar Health, Inc. (NYSE:OSCR)

US Bancorp DE lowered its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 19.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,051 shares of the company’s stock after selling 4,733 shares during the period. US Bancorp DE’s holdings in Oscar Health were worth $269,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. KBC Group NV grew its position in shares of Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health during the fourth quarter worth approximately $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health during the fourth quarter worth approximately $138,000. SMART Wealth LLC acquired a new stake in shares of Oscar Health during the fourth quarter worth approximately $180,000. Finally, Tempus Wealth Planning LLC acquired a new stake in shares of Oscar Health during the fourth quarter worth approximately $181,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

OSCR opened at $13.23 on Friday. The business’s 50 day moving average is $15.21 and its 200-day moving average is $16.39. The stock has a market cap of $3.31 billion, a PE ratio of -660.92 and a beta of 1.75. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $12.43 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

OSCR has been the subject of several recent research reports. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Oscar Health has a consensus rating of “Hold” and an average price target of $20.19.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.